Madrona Venture Group
Latest statistics and disclosures from Madrona Venture Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PATH, NAUT, DNA, and represent 100.00% of Madrona Venture Group's stock portfolio.
- Madrona Venture Group has $14M in assets under management (AUM), dropping by 9.65%.
- Central Index Key (CIK): 0001887785
Tip: Access up to 7 years of quarterly data
Positions held by Madrona Venture Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Madrona Venture Group
Madrona Venture Group holds 3 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uipath Cl A (PATH) | 58.8 | $8.1M | 608k | 13.38 |
|
|
| Nautilus Biotechnology (NAUT) | 36.8 | $5.1M | 6.0M | 0.84 |
|
|
| Ginkgo Bioworks Holdings Cl A (DNA) | 4.5 | $619k | 42k | 14.59 |
|
Past Filings by Madrona Venture Group
SEC 13F filings are viewable for Madrona Venture Group going back to 2020
- Madrona Venture Group 2025 Q3 filed Oct. 31, 2025
- Madrona Venture Group 2025 Q2 filed Aug. 11, 2025
- Madrona Venture Group 2025 Q1 filed May 7, 2025
- Madrona Venture Group 2024 Q4 filed Feb. 14, 2025
- Madrona Venture Group 2024 Q3 filed Nov. 4, 2024
- Madrona Venture Group 2024 Q2 filed July 25, 2024
- Madrona Venture Group 2024 Q1 filed May 8, 2024
- Madrona Venture Group 2023 Q4 filed Jan. 30, 2024
- Madrona Venture Group 2023 Q3 filed Nov. 8, 2023
- Madrona Venture Group 2023 Q2 filed Aug. 3, 2023
- Madrona Venture Group 2022 Q1 amended filed May 5, 2023
- Madrona Venture Group 2022 Q2 amended filed May 5, 2023
- Madrona Venture Group 2022 Q3 amended filed May 5, 2023
- Madrona Venture Group 2022 Q4 amended filed May 5, 2023
- Madrona Venture Group 2023 Q1 filed May 5, 2023
- Madrona Venture Group 2022 Q4 filed Feb. 8, 2023